Lee, I. H., Kang, B. W., Kim, J. G., Bae, W. K., Ki, M. S., Park, I., . . . Lee, S. A. (2020). Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy. Korean J Intern Med.
Stile di citazione ChicagoLee, In Hee, et al. "Comparison of Three Risk Stratification Models for Non-clear Cell Renal Cell Carcinoma Patients Treated With Temsirolimus As First-line Therapy." Korean J Intern Med 2020.
Citazione MLALee, In Hee, et al. "Comparison of Three Risk Stratification Models for Non-clear Cell Renal Cell Carcinoma Patients Treated With Temsirolimus As First-line Therapy." Korean J Intern Med 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.